Precision Virologics

Developing biologically targeted adenovirus vaccines to treat infectious diseases

placeSt. Louis, Missouri, United States calendar_todayFounded 2016 groups2 employees language precisionvx.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon